Clin2
NCT07876076Likely a fitNot yet recruiting

Testing a new medicine for safety in healthy adults

Healthy

This trial tests a new medicine called ADX-001 in healthy adults to see if it is safe, how the body handles it, and whether it triggers an immune response. It is an early-stage study, so it will help determine if the drug is safe enough for further testing in people with certain conditions.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
88 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • Be a healthy adult aged 18 to 55
  • Have a body mass index (BMI) between 18 and 32
  • Weigh between 50 and 120 kg (about 110 to 265 pounds)
  • Test negative for HIV, hepatitis B, hepatitis C, and COVID-19 before dosing
  • Agree to use highly effective birth control during the study and for 15 months after the last dose (if you can become pregnant)
  • Have no serious health conditions, recent infections, or recent use of certain medications

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07606976Not yet recruiting· Phase 1
Study of a new medicine in healthy adults

This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.

Shanghai
NCT07678463Recruiting· Phase 1
Testing a new medicine in healthy volunteers

This study tests a new experimental medication (QX-4533) in healthy volunteers to find the best dose and see how it works in the body. It involves taking the medication and having your health monitored closely over time.

Brisbane, Queensland
NCT07235163Recruiting· Phase 1
Testing a new medicine in healthy adults

This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.

Brussels, Bruxelles-capitale, Région de
NCT06845839Recruiting· Phase 1
Testing a new drug in healthy volunteers

This trial tests a new drug called CAY001 in healthy volunteers to see how safe it is and how the body processes it. It may help researchers understand if the drug is safe enough to test in people with medical conditions later.

Fair Lawn, New Jersey
NCT07081503Recruiting· Phase 1
Testing ADX-626 in healthy adults

This study tests a new investigational drug called ADX-626 in healthy volunteers for the first time in humans. The goal is to see how the drug is processed by the body and whether it is safe, helping to decide if it can be studied in future patients.

London
NCT07140055Not yet recruiting· Phase 1
Testing a new study drug in healthy adults

This study tests a new medicine called BLX-7006 in healthy adults to see if it is safe and to learn how the body handles it. Participating could help decide if the drug should be tested in people with certain conditions later.

Brisbane, Queensland

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.